Another innovation to regulate the promotion of medical products were made in 2014. Special attention was paid to communication between the employees of the drug companies and the medical community.
The regulatory framework is extended with the following Federal laws:
the Basic principles of communication between the employees of the drug companies and the medical community are in the truthfulness and completeness of the information, which can adversely affect product properties, and prohibiting unethical way to promote a medical discharge and sale of medicines.
In the Russian system of regulation of relations between the pharmaceutical companies and the medical community are actively involved and also the companies themselves through self-regulation and updating of the code of AIPM.
From all of the above we can conclude about the presence in our country of a bilateral system of norms and rules — the legislation of the Russian Federation and the code of ethics.
so, let’s talk about legal restrictions in more detail.
regulation of the interaction between business and the medical community was launched in 2011 with the entry into force of the Federal law «About bases of health protection of citizens in the Russian Federation». The article «the Limitations imposed on medical and pharmaceutical workers in the exercise of professional activity» means the precise bounding box of professional interaction doctors and other medical staff with representatives of pharmaceutical companies.
Also legal system regulates the activities of pharmaceutical companies. Article 67 and article 74 dictates the rules of various events, including those aimed at improving the skills of health workers. It refers to those activities that have the right to attend Medical representatives – round tables, conferences, farmcrest, fovy, Fussy and others.
Pursuant to article 14.1 about the limitations imposed on the organization carrying out the activity on circulation of medicines — now employees of the health system can’t take from representatives of pharmaceutical companies various kinds of gifts in any form, in turn, the company can’t give them. Also, Pharma companies can encourage doctors and other professionals of the medical community financially, can’t give the doctors and staff of pharmacies free samples and ask for the prescription blanks with the name of the drug and both parties must not intentionally hide important information about side effects and other similar drugs.
thus the authorities are trying to make the conditions of cooperation between manufacturers and the medical community more transparent and honest. It also helps to level the playing field of competitors in regard to product promotion.
Now let us come to the issue of restraint of pharmaceutical companies.
Rules of self-restraint are developed jointly by pharmaceutical manufacturers that have merged into the Association of international pharmaceutical manufacturers (AIPM) and has created its own code. Ethical and regulatory standards, are combined in the code contain rules for interaction between pharmaceutical manufacturers with representatives of the medical community working in the health care system. These limits are only recommended. More with the code and with the companies — members of the organization can be found on the website http://www.aipm.org/.
There are exceptions to the rule and not all pharmaceutical companies comply with legislation and ethical standards developed by AIPM, blatantly violating them in order to raise your sales. But most of the major pharmaceutical manufacturers provide their sales due to the high quality of the product, its efficacy and safety for patients.
1http://www.consultant.ru/document/cons_doc_LAW_170232/
2http://www.consultant.ru/document/cons_doc_LAW_166101/
3http://www.consultant.ru/document/cons_doc_LAW_173296/
Daria Gavrilova,
Recruiting company AVICONN
The recruitment consultant.